Product Review - Darunavir/cobicistat treatment of HIV-1 infection


This review discusses HIV burden, available treatments, properties, contraindications and some of the key studies to date. It also provides commentary and recommendations from Professor Andrew Carr, St Vincent’s Hospital, Sydney’s Director of the HIV, Immunology and Infectious Diseases Unit, and Head of the Clinical Research Program, Centre for Applied Medical Research.

Please login below to download this issue (PDF)